MED SCI MONITOR 润色咨询

MEDICAL SCIENCE MONITOR

出版年份:暂无数据 年文章数:6066 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:14.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2198092, encodeId=08962198092dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:围产医学;危急重症<br>经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~<br>2024-04-11<br>Accepted - invoice issued<br>2024-04-11<br>1st Post-Rev plagiarism check ready<br>2024-04-11<br>Sent for 1st Post-Rev antiplagiarism check<br>2024-04-11<br>Ready for Post-Rev antiplagiarism check<br>2024-04-11<br>After authors corrections<br>2024-04-11<br>Sent to author(s) for corrections (1 week)<br>2024-04-11<br>Reconsider after revision<br>2024-04-09<br>Review 2 pending<br>2024-04-08<br>Review 2 requests sent to reviewers<br>2024-04-05<br>After authors corrections<br>2024-03-22<br>Sent to author(s) for corrections (2 weeks)<br>2024-03-22<br>Reconsider after revision<br>2024-03-22<br>Awaiting decision<br>2024-03-22<br>2nd Scientific Triage Completed<br>2024-03-22<br>In 2nd Scientific triage<br>2024-03-11<br>Review pending<br>2024-03-11<br>Evaluation requests sent to reviewers<br>2024-02-26<br>Review pending<br>2024-01-24<br>Evaluation requests sent to reviewers<br>2024-01-23<br>Scientific triage completed<br>2024-01-23<br>In scientific triage<br>2024-01-23<br>Manuscript accepted for processing<br>2024-01-23<br>Plagiarism check (submission) 1 ready<br>2024-01-23<br>Sent for anti-plagiarism verification<br>2024-01-23<br>Submissions Approved<br>2024-01-20<br>Incomplete - corrected file uploaded<br>2024-01-16<br>Incomplete - submission needs correction<br>2024-01-15<br>Incomplete - corrected file uploaded<br>2024-01-11<br>Incomplete - submission needs correction<br>2024-01-11<br>Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Fri Apr 12 07:44:45 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198964, encodeId=6e6a21989640b, content=好好做临床,努力发文章,争取中课题!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08ca9261070, createdName=ms3000000978137642, createdTime=Wed Apr 17 15:22:08 CST 2024, time=2024-04-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省)]
    2023-01-20 ms9354616365725748 来自江苏省

    这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2198092, encodeId=08962198092dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:围产医学;危急重症<br>经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~<br>2024-04-11<br>Accepted - invoice issued<br>2024-04-11<br>1st Post-Rev plagiarism check ready<br>2024-04-11<br>Sent for 1st Post-Rev antiplagiarism check<br>2024-04-11<br>Ready for Post-Rev antiplagiarism check<br>2024-04-11<br>After authors corrections<br>2024-04-11<br>Sent to author(s) for corrections (1 week)<br>2024-04-11<br>Reconsider after revision<br>2024-04-09<br>Review 2 pending<br>2024-04-08<br>Review 2 requests sent to reviewers<br>2024-04-05<br>After authors corrections<br>2024-03-22<br>Sent to author(s) for corrections (2 weeks)<br>2024-03-22<br>Reconsider after revision<br>2024-03-22<br>Awaiting decision<br>2024-03-22<br>2nd Scientific Triage Completed<br>2024-03-22<br>In 2nd Scientific triage<br>2024-03-11<br>Review pending<br>2024-03-11<br>Evaluation requests sent to reviewers<br>2024-02-26<br>Review pending<br>2024-01-24<br>Evaluation requests sent to reviewers<br>2024-01-23<br>Scientific triage completed<br>2024-01-23<br>In scientific triage<br>2024-01-23<br>Manuscript accepted for processing<br>2024-01-23<br>Plagiarism check (submission) 1 ready<br>2024-01-23<br>Sent for anti-plagiarism verification<br>2024-01-23<br>Submissions Approved<br>2024-01-20<br>Incomplete - corrected file uploaded<br>2024-01-16<br>Incomplete - submission needs correction<br>2024-01-15<br>Incomplete - corrected file uploaded<br>2024-01-11<br>Incomplete - submission needs correction<br>2024-01-11<br>Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Fri Apr 12 07:44:45 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198964, encodeId=6e6a21989640b, content=好好做临床,努力发文章,争取中课题!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08ca9261070, createdName=ms3000000978137642, createdTime=Wed Apr 17 15:22:08 CST 2024, time=2024-04-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省)]
    2024-03-10 ms5000000983971375 来自陕西省

    投稿命中率:95.0
    偏重的研究方向:临床研究
    经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2198092, encodeId=08962198092dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:围产医学;危急重症<br>经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~<br>2024-04-11<br>Accepted - invoice issued<br>2024-04-11<br>1st Post-Rev plagiarism check ready<br>2024-04-11<br>Sent for 1st Post-Rev antiplagiarism check<br>2024-04-11<br>Ready for Post-Rev antiplagiarism check<br>2024-04-11<br>After authors corrections<br>2024-04-11<br>Sent to author(s) for corrections (1 week)<br>2024-04-11<br>Reconsider after revision<br>2024-04-09<br>Review 2 pending<br>2024-04-08<br>Review 2 requests sent to reviewers<br>2024-04-05<br>After authors corrections<br>2024-03-22<br>Sent to author(s) for corrections (2 weeks)<br>2024-03-22<br>Reconsider after revision<br>2024-03-22<br>Awaiting decision<br>2024-03-22<br>2nd Scientific Triage Completed<br>2024-03-22<br>In 2nd Scientific triage<br>2024-03-11<br>Review pending<br>2024-03-11<br>Evaluation requests sent to reviewers<br>2024-02-26<br>Review pending<br>2024-01-24<br>Evaluation requests sent to reviewers<br>2024-01-23<br>Scientific triage completed<br>2024-01-23<br>In scientific triage<br>2024-01-23<br>Manuscript accepted for processing<br>2024-01-23<br>Plagiarism check (submission) 1 ready<br>2024-01-23<br>Sent for anti-plagiarism verification<br>2024-01-23<br>Submissions Approved<br>2024-01-20<br>Incomplete - corrected file uploaded<br>2024-01-16<br>Incomplete - submission needs correction<br>2024-01-15<br>Incomplete - corrected file uploaded<br>2024-01-11<br>Incomplete - submission needs correction<br>2024-01-11<br>Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Fri Apr 12 07:44:45 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198964, encodeId=6e6a21989640b, content=好好做临床,努力发文章,争取中课题!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08ca9261070, createdName=ms3000000978137642, createdTime=Wed Apr 17 15:22:08 CST 2024, time=2024-04-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省)]
    2024-04-12 ms7000000888761661 来自江苏省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:围产医学;危急重症
    经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~
    2024-04-11
    Accepted - invoice issued
    2024-04-11
    1st Post-Rev plagiarism check ready
    2024-04-11
    Sent for 1st Post-Rev antiplagiarism check
    2024-04-11
    Ready for Post-Rev antiplagiarism check
    2024-04-11
    After authors corrections
    2024-04-11
    Sent to author(s) for corrections (1 week)
    2024-04-11
    Reconsider after revision
    2024-04-09
    Review 2 pending
    2024-04-08
    Review 2 requests sent to reviewers
    2024-04-05
    After authors corrections
    2024-03-22
    Sent to author(s) for corrections (2 weeks)
    2024-03-22
    Reconsider after revision
    2024-03-22
    Awaiting decision
    2024-03-22
    2nd Scientific Triage Completed
    2024-03-22
    In 2nd Scientific triage
    2024-03-11
    Review pending
    2024-03-11
    Evaluation requests sent to reviewers
    2024-02-26
    Review pending
    2024-01-24
    Evaluation requests sent to reviewers
    2024-01-23
    Scientific triage completed
    2024-01-23
    In scientific triage
    2024-01-23
    Manuscript accepted for processing
    2024-01-23
    Plagiarism check (submission) 1 ready
    2024-01-23
    Sent for anti-plagiarism verification
    2024-01-23
    Submissions Approved
    2024-01-20
    Incomplete - corrected file uploaded
    2024-01-16
    Incomplete - submission needs correction
    2024-01-15
    Incomplete - corrected file uploaded
    2024-01-11
    Incomplete - submission needs correction
    2024-01-11
    Submission Received

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2198092, encodeId=08962198092dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:围产医学;危急重症<br>经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~<br>2024-04-11<br>Accepted - invoice issued<br>2024-04-11<br>1st Post-Rev plagiarism check ready<br>2024-04-11<br>Sent for 1st Post-Rev antiplagiarism check<br>2024-04-11<br>Ready for Post-Rev antiplagiarism check<br>2024-04-11<br>After authors corrections<br>2024-04-11<br>Sent to author(s) for corrections (1 week)<br>2024-04-11<br>Reconsider after revision<br>2024-04-09<br>Review 2 pending<br>2024-04-08<br>Review 2 requests sent to reviewers<br>2024-04-05<br>After authors corrections<br>2024-03-22<br>Sent to author(s) for corrections (2 weeks)<br>2024-03-22<br>Reconsider after revision<br>2024-03-22<br>Awaiting decision<br>2024-03-22<br>2nd Scientific Triage Completed<br>2024-03-22<br>In 2nd Scientific triage<br>2024-03-11<br>Review pending<br>2024-03-11<br>Evaluation requests sent to reviewers<br>2024-02-26<br>Review pending<br>2024-01-24<br>Evaluation requests sent to reviewers<br>2024-01-23<br>Scientific triage completed<br>2024-01-23<br>In scientific triage<br>2024-01-23<br>Manuscript accepted for processing<br>2024-01-23<br>Plagiarism check (submission) 1 ready<br>2024-01-23<br>Sent for anti-plagiarism verification<br>2024-01-23<br>Submissions Approved<br>2024-01-20<br>Incomplete - corrected file uploaded<br>2024-01-16<br>Incomplete - submission needs correction<br>2024-01-15<br>Incomplete - corrected file uploaded<br>2024-01-11<br>Incomplete - submission needs correction<br>2024-01-11<br>Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Fri Apr 12 07:44:45 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198964, encodeId=6e6a21989640b, content=好好做临床,努力发文章,争取中课题!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08ca9261070, createdName=ms3000000978137642, createdTime=Wed Apr 17 15:22:08 CST 2024, time=2024-04-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省)]
    2024-04-17 ms3000000978137642 来自山东省

    好好做临床,努力发文章,争取中课题!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2198092, encodeId=08962198092dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:围产医学;危急重症<br>经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~<br>2024-04-11<br>Accepted - invoice issued<br>2024-04-11<br>1st Post-Rev plagiarism check ready<br>2024-04-11<br>Sent for 1st Post-Rev antiplagiarism check<br>2024-04-11<br>Ready for Post-Rev antiplagiarism check<br>2024-04-11<br>After authors corrections<br>2024-04-11<br>Sent to author(s) for corrections (1 week)<br>2024-04-11<br>Reconsider after revision<br>2024-04-09<br>Review 2 pending<br>2024-04-08<br>Review 2 requests sent to reviewers<br>2024-04-05<br>After authors corrections<br>2024-03-22<br>Sent to author(s) for corrections (2 weeks)<br>2024-03-22<br>Reconsider after revision<br>2024-03-22<br>Awaiting decision<br>2024-03-22<br>2nd Scientific Triage Completed<br>2024-03-22<br>In 2nd Scientific triage<br>2024-03-11<br>Review pending<br>2024-03-11<br>Evaluation requests sent to reviewers<br>2024-02-26<br>Review pending<br>2024-01-24<br>Evaluation requests sent to reviewers<br>2024-01-23<br>Scientific triage completed<br>2024-01-23<br>In scientific triage<br>2024-01-23<br>Manuscript accepted for processing<br>2024-01-23<br>Plagiarism check (submission) 1 ready<br>2024-01-23<br>Sent for anti-plagiarism verification<br>2024-01-23<br>Submissions Approved<br>2024-01-20<br>Incomplete - corrected file uploaded<br>2024-01-16<br>Incomplete - submission needs correction<br>2024-01-15<br>Incomplete - corrected file uploaded<br>2024-01-11<br>Incomplete - submission needs correction<br>2024-01-11<br>Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Fri Apr 12 07:44:45 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198964, encodeId=6e6a21989640b, content=好好做临床,努力发文章,争取中课题!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08ca9261070, createdName=ms3000000978137642, createdTime=Wed Apr 17 15:22:08 CST 2024, time=2024-04-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省)]
    2024-03-01 Unparalled 来自浙江省

    在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2198092, encodeId=08962198092dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:围产医学;危急重症<br>经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~<br>2024-04-11<br>Accepted - invoice issued<br>2024-04-11<br>1st Post-Rev plagiarism check ready<br>2024-04-11<br>Sent for 1st Post-Rev antiplagiarism check<br>2024-04-11<br>Ready for Post-Rev antiplagiarism check<br>2024-04-11<br>After authors corrections<br>2024-04-11<br>Sent to author(s) for corrections (1 week)<br>2024-04-11<br>Reconsider after revision<br>2024-04-09<br>Review 2 pending<br>2024-04-08<br>Review 2 requests sent to reviewers<br>2024-04-05<br>After authors corrections<br>2024-03-22<br>Sent to author(s) for corrections (2 weeks)<br>2024-03-22<br>Reconsider after revision<br>2024-03-22<br>Awaiting decision<br>2024-03-22<br>2nd Scientific Triage Completed<br>2024-03-22<br>In 2nd Scientific triage<br>2024-03-11<br>Review pending<br>2024-03-11<br>Evaluation requests sent to reviewers<br>2024-02-26<br>Review pending<br>2024-01-24<br>Evaluation requests sent to reviewers<br>2024-01-23<br>Scientific triage completed<br>2024-01-23<br>In scientific triage<br>2024-01-23<br>Manuscript accepted for processing<br>2024-01-23<br>Plagiarism check (submission) 1 ready<br>2024-01-23<br>Sent for anti-plagiarism verification<br>2024-01-23<br>Submissions Approved<br>2024-01-20<br>Incomplete - corrected file uploaded<br>2024-01-16<br>Incomplete - submission needs correction<br>2024-01-15<br>Incomplete - corrected file uploaded<br>2024-01-11<br>Incomplete - submission needs correction<br>2024-01-11<br>Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Fri Apr 12 07:44:45 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198964, encodeId=6e6a21989640b, content=好好做临床,努力发文章,争取中课题!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08ca9261070, createdName=ms3000000978137642, createdTime=Wed Apr 17 15:22:08 CST 2024, time=2024-04-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省)]
    2024-03-14 ms5000000983971375 来自陕西省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:临床研究;科研
    经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2198092, encodeId=08962198092dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:围产医学;危急重症<br>经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~<br>2024-04-11<br>Accepted - invoice issued<br>2024-04-11<br>1st Post-Rev plagiarism check ready<br>2024-04-11<br>Sent for 1st Post-Rev antiplagiarism check<br>2024-04-11<br>Ready for Post-Rev antiplagiarism check<br>2024-04-11<br>After authors corrections<br>2024-04-11<br>Sent to author(s) for corrections (1 week)<br>2024-04-11<br>Reconsider after revision<br>2024-04-09<br>Review 2 pending<br>2024-04-08<br>Review 2 requests sent to reviewers<br>2024-04-05<br>After authors corrections<br>2024-03-22<br>Sent to author(s) for corrections (2 weeks)<br>2024-03-22<br>Reconsider after revision<br>2024-03-22<br>Awaiting decision<br>2024-03-22<br>2nd Scientific Triage Completed<br>2024-03-22<br>In 2nd Scientific triage<br>2024-03-11<br>Review pending<br>2024-03-11<br>Evaluation requests sent to reviewers<br>2024-02-26<br>Review pending<br>2024-01-24<br>Evaluation requests sent to reviewers<br>2024-01-23<br>Scientific triage completed<br>2024-01-23<br>In scientific triage<br>2024-01-23<br>Manuscript accepted for processing<br>2024-01-23<br>Plagiarism check (submission) 1 ready<br>2024-01-23<br>Sent for anti-plagiarism verification<br>2024-01-23<br>Submissions Approved<br>2024-01-20<br>Incomplete - corrected file uploaded<br>2024-01-16<br>Incomplete - submission needs correction<br>2024-01-15<br>Incomplete - corrected file uploaded<br>2024-01-11<br>Incomplete - submission needs correction<br>2024-01-11<br>Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Fri Apr 12 07:44:45 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198964, encodeId=6e6a21989640b, content=好好做临床,努力发文章,争取中课题!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08ca9261070, createdName=ms3000000978137642, createdTime=Wed Apr 17 15:22:08 CST 2024, time=2024-04-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省)]
    2023-11-23 ms5000000983971375 来自陕西省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:综合
    经验分享:从投到接收不到2个月,总的来说挺快的

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2198092, encodeId=08962198092dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:围产医学;危急重症<br>经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~<br>2024-04-11<br>Accepted - invoice issued<br>2024-04-11<br>1st Post-Rev plagiarism check ready<br>2024-04-11<br>Sent for 1st Post-Rev antiplagiarism check<br>2024-04-11<br>Ready for Post-Rev antiplagiarism check<br>2024-04-11<br>After authors corrections<br>2024-04-11<br>Sent to author(s) for corrections (1 week)<br>2024-04-11<br>Reconsider after revision<br>2024-04-09<br>Review 2 pending<br>2024-04-08<br>Review 2 requests sent to reviewers<br>2024-04-05<br>After authors corrections<br>2024-03-22<br>Sent to author(s) for corrections (2 weeks)<br>2024-03-22<br>Reconsider after revision<br>2024-03-22<br>Awaiting decision<br>2024-03-22<br>2nd Scientific Triage Completed<br>2024-03-22<br>In 2nd Scientific triage<br>2024-03-11<br>Review pending<br>2024-03-11<br>Evaluation requests sent to reviewers<br>2024-02-26<br>Review pending<br>2024-01-24<br>Evaluation requests sent to reviewers<br>2024-01-23<br>Scientific triage completed<br>2024-01-23<br>In scientific triage<br>2024-01-23<br>Manuscript accepted for processing<br>2024-01-23<br>Plagiarism check (submission) 1 ready<br>2024-01-23<br>Sent for anti-plagiarism verification<br>2024-01-23<br>Submissions Approved<br>2024-01-20<br>Incomplete - corrected file uploaded<br>2024-01-16<br>Incomplete - submission needs correction<br>2024-01-15<br>Incomplete - corrected file uploaded<br>2024-01-11<br>Incomplete - submission needs correction<br>2024-01-11<br>Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Fri Apr 12 07:44:45 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198964, encodeId=6e6a21989640b, content=好好做临床,努力发文章,争取中课题!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08ca9261070, createdName=ms3000000978137642, createdTime=Wed Apr 17 15:22:08 CST 2024, time=2024-04-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省)]
    2024-02-27 大星猩 来自东京都

    审稿速度:6.0
    经验分享:2024-02-25
    Rejected - suggested journal transfer
    Note: suggested_to Clinical Practice Review and Meta-Analysis
    2024-01-15
    Awaiting decision

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2198092, encodeId=08962198092dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:围产医学;危急重症<br>经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~<br>2024-04-11<br>Accepted - invoice issued<br>2024-04-11<br>1st Post-Rev plagiarism check ready<br>2024-04-11<br>Sent for 1st Post-Rev antiplagiarism check<br>2024-04-11<br>Ready for Post-Rev antiplagiarism check<br>2024-04-11<br>After authors corrections<br>2024-04-11<br>Sent to author(s) for corrections (1 week)<br>2024-04-11<br>Reconsider after revision<br>2024-04-09<br>Review 2 pending<br>2024-04-08<br>Review 2 requests sent to reviewers<br>2024-04-05<br>After authors corrections<br>2024-03-22<br>Sent to author(s) for corrections (2 weeks)<br>2024-03-22<br>Reconsider after revision<br>2024-03-22<br>Awaiting decision<br>2024-03-22<br>2nd Scientific Triage Completed<br>2024-03-22<br>In 2nd Scientific triage<br>2024-03-11<br>Review pending<br>2024-03-11<br>Evaluation requests sent to reviewers<br>2024-02-26<br>Review pending<br>2024-01-24<br>Evaluation requests sent to reviewers<br>2024-01-23<br>Scientific triage completed<br>2024-01-23<br>In scientific triage<br>2024-01-23<br>Manuscript accepted for processing<br>2024-01-23<br>Plagiarism check (submission) 1 ready<br>2024-01-23<br>Sent for anti-plagiarism verification<br>2024-01-23<br>Submissions Approved<br>2024-01-20<br>Incomplete - corrected file uploaded<br>2024-01-16<br>Incomplete - submission needs correction<br>2024-01-15<br>Incomplete - corrected file uploaded<br>2024-01-11<br>Incomplete - submission needs correction<br>2024-01-11<br>Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Fri Apr 12 07:44:45 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198964, encodeId=6e6a21989640b, content=好好做临床,努力发文章,争取中课题!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08ca9261070, createdName=ms3000000978137642, createdTime=Wed Apr 17 15:22:08 CST 2024, time=2024-04-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省)]
    2024-02-26 Unparalled 来自浙江省

    它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2198092, encodeId=08962198092dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:围产医学;危急重症<br>经验分享:分享一下,整整三个月,编辑态度非常好,站内消息1天内回复。审稿人的话,看的出来可能不是专业的方向的医生(可能是学术型的研究者),专业知识的把控比较松,但是对整体设计和统计相对严格,而且检查的很仔细,错了一个单词都被发现了。一审大修,三个人一起补了整整一周的数据。二审改两个单词,我刚上传10min就接收了~<br>2024-04-11<br>Accepted - invoice issued<br>2024-04-11<br>1st Post-Rev plagiarism check ready<br>2024-04-11<br>Sent for 1st Post-Rev antiplagiarism check<br>2024-04-11<br>Ready for Post-Rev antiplagiarism check<br>2024-04-11<br>After authors corrections<br>2024-04-11<br>Sent to author(s) for corrections (1 week)<br>2024-04-11<br>Reconsider after revision<br>2024-04-09<br>Review 2 pending<br>2024-04-08<br>Review 2 requests sent to reviewers<br>2024-04-05<br>After authors corrections<br>2024-03-22<br>Sent to author(s) for corrections (2 weeks)<br>2024-03-22<br>Reconsider after revision<br>2024-03-22<br>Awaiting decision<br>2024-03-22<br>2nd Scientific Triage Completed<br>2024-03-22<br>In 2nd Scientific triage<br>2024-03-11<br>Review pending<br>2024-03-11<br>Evaluation requests sent to reviewers<br>2024-02-26<br>Review pending<br>2024-01-24<br>Evaluation requests sent to reviewers<br>2024-01-23<br>Scientific triage completed<br>2024-01-23<br>In scientific triage<br>2024-01-23<br>Manuscript accepted for processing<br>2024-01-23<br>Plagiarism check (submission) 1 ready<br>2024-01-23<br>Sent for anti-plagiarism verification<br>2024-01-23<br>Submissions Approved<br>2024-01-20<br>Incomplete - corrected file uploaded<br>2024-01-16<br>Incomplete - submission needs correction<br>2024-01-15<br>Incomplete - corrected file uploaded<br>2024-01-11<br>Incomplete - submission needs correction<br>2024-01-11<br>Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d01a5503273, createdName=ms7000000888761661, createdTime=Fri Apr 12 07:44:45 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198964, encodeId=6e6a21989640b, content=好好做临床,努力发文章,争取中课题!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08ca9261070, createdName=ms3000000978137642, createdTime=Wed Apr 17 15:22:08 CST 2024, time=2024-04-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省)]
    2024-02-27 ms4000000240525001 来自安徽省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。

    0

共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分